Identification Generic Name (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid DrugBank Accession Number DB07189 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid (DB07189) ×  Close Weight Average: 464.5119  Monoisotopic: 464.173607266  Chemical Formula C 29 H 24 N 2 O 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Disintegrin and metalloproteinase domain-containing protein 17 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Quinolines and derivatives Sub Class Phenylquinolines Direct Parent Phenylquinolines Alternative Parents Phenylpyridines  /  Phenylpyrrolidines  /  Phenol ethers  /  Phenoxy compounds  /  Alkyl aryl ethers  /  Cyclopropanecarboxylic acids  /  Pyrrolidine-2-ones  /  Heteroaromatic compounds  /  Pyrroles  /  Lactams  /  Secondary carboxylic acid amides  /  Monocarboxylic acids and derivatives  /  Carboxylic acids  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 9 more Substituents 2-phenylpyridine  /  2-phenylpyrrolidine  /  2-pyrrolidone  /  Alkyl aryl ether  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid  /  Carboxylic acid derivative  /  Cyclopropanecarboxylic acid  /  Cyclopropanecarboxylic acid or derivatives  /  Ether  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Lactam  /  Monocarboxylic acid or derivatives  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Phenol ether  /  Phenoxy compound  /  Phenylquinoline  /  Pyridine  /  Pyrrole  /  Pyrrolidine  /  Pyrrolidone  /  Secondary carboxylic acid amide 
 
 
  show 23 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key BFZXMIUWGSTUAL-ZSOKXDGFSA-N InChI InChI=1S/C29H24N2O4/c32-27(33)23-15-29(23)16-26(31-28(29)34)19-10-12-21(13-11-19)35-17-20-14-25(18-6-2-1-3-7-18)30-24-9-5-4-8-22(20)24/h1-14,23,26H,15-17H2,(H,31,34)(H,32,33)/t23-,26+,29-/m1/s1 IUPAC Name (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid SMILES [H][C@@]1(C[C@@]11C[C@]([H])(NC1=O)C1=CC=C(OCC2=CC(=NC3=C2C=CC=C3)C2=CC=CC=C2)C=C1)C(O)=O References General References Not Available External Links PubChem Compound 25049750 PubChem Substance 99443660 ChemSpider 25056739 ZINC ZINC000040891582 PDBe Ligand 642 PDB Entries 3ewj Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.000513 mg/mL ALOGPS logP 4.59 ALOGPS logP 4.3 Chemaxon logS -6 ALOGPS pKa (Strongest Acidic) 4.09 Chemaxon pKa (Strongest Basic) 3.46 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 88.52 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 129.82 m 3 ·mol -1 Chemaxon Polarizability 50.58 Å 3 Chemaxon Number of Rings 6 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9508 Blood Brain Barrier + 0.8294 Caco-2 permeable - 0.7845 P-glycoprotein substrate Substrate 0.637 P-glycoprotein inhibitor I Non-inhibitor 0.9585 P-glycoprotein inhibitor II Non-inhibitor 0.7752 Renal organic cation transporter Non-inhibitor 0.8173 CYP450 2C9 substrate Non-substrate 0.8251 CYP450 2D6 substrate Non-substrate 0.782 CYP450 3A4 substrate Substrate 0.5444 CYP450 1A2 substrate Non-inhibitor 0.5303 CYP450 2C9 inhibitor Non-inhibitor 0.602 CYP450 2D6 inhibitor Non-inhibitor 0.7299 CYP450 2C19 inhibitor Non-inhibitor 0.7582 CYP450 3A4 inhibitor Non-inhibitor 0.5542 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.6544 Ames test Non AMES toxic 0.7919 Carcinogenicity Non-carcinogens 0.9222 Biodegradation Not ready biodegradable 0.9921 Rat acute toxicity 2.6694 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9978 hERG inhibition (predictor II) Non-inhibitor 0.7502    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Disintegrin and metalloproteinase domain-containing protein 17 Kind Protein Organism Humans Pharmacological action Unknown General Function Zinc ion binding Specific Function Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolyt... Gene Name ADAM17 Uniprot ID P78536 Uniprot Name Disintegrin and metalloproteinase domain-containing protein 17 Molecular Weight 93020.165 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:19 / Updated at June 12, 2020 16:52 